Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Therapeutic Advances in Medical Oncology|January 19, 2018
Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: reviewTomás Reinert, Carlos H BarriosCurrent Opinion in Oncology|August 22, 2021
Open questions and controversies in the systemic treatment of breast cancerCarlos Henrique Barrios, Tomás ReinertClinical Pharmacology and Therapeutics|December 12, 2017
Emerging Innovative Therapeutic Approaches Leveraging Cyclin-Dependent Kinase Inhibitors to Treat Advanced Breast CancerMarcelo Cruz, Tomás Reinert, Massimo CristofanilliCurrent Treatment Options in Oncology|April 19, 2018
Implications of ESR1 Mutations in Hormone Receptor-Positive Breast CancerTomás Reinert, Rodrigo Gonçalves, José BinesEcancermedicalscience|July 16, 2021
Cost-effectiveness of breast, lung, colon, prostate and cervical cancer outcomes in Brazil: a worldwide comparisonRodrigo Pellegrini, Tomás Reinert, Carlos Henrique BarriosEcancermedicalscience|February 23, 2019
Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumabCarlos Henrique Barrios, Tomás Reinert, Gustavo WerutskyCurrent Treatment Options in Oncology|April 18, 2018
Current Status of Neoadjuvant Endocrine Therapy in Early Stage Breast CancerTomás Reinert, Rodrigo Gonçalves, Matthew J EllisEcancermedicalscience|September 1, 2020
Lack of access to CDK4/6 inhibitors for premenopausal patients with metastatic breast cancer in Brazil: estimation of the number of premature deathsTomás Reinert, Rodrigo Pellegrini, Carlos Henrique BarriosAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Breast Cancer Research: Moving ForwardCarlos H Barrios, Tomás Reinert, Gustavo WerutskyNature Reviews. Cancer|April 25, 2015
Mechanisms of aromatase inhibitor resistanceCynthia X Ma, Tomás Reinert, Izabela Chmielewska, et al.Pageof 5